FDA 483 - OMID Holdings Inc. - October 15, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of OMID Holdings Inc., a dietary supplement manufacturer in Alpha, NJ, revealed significant deficiencies in their manufacturing and quality control processes. The firm failed to establish necessary specifications for components and finished products, maintain adequate master and batch production records, and ensure proper calibration of equipment. Additionally, personnel lacked formal training in current good manufacturing practices for dietary supplements.
ID · b3812fda-6df9-4b16-9f51-4d03eba5aa20